Gin Malhi, MD, University of Sydney
Do the DSM criteria for ADHD hold up under scrutiny? These doctors say no
STUDY: Ophir Y, Br J Psychiatry 2026;1–5; Szymaniak K et al, Br J Psychiatry 2026
STUDY TYPE: Commentary (response to Ophir, 2026)
FUNDING: Independent
Background
A UK documentary, The Great ADHD Myth?, reignited public debate over how ADHD is diagnosed. Here, psychiatrists and psychologists from around the world address the controversy through editorials from the British Journal of Psychiatry.
Evolution of the Criteria

Yaakov Ophir, PhD, Hebrew University of Jerusalem
Dr. Yaakov Ophir explored how the DSM criteria has changed from DSM-III (1980) to DSM-5-TR (2022).
The criteria has expanded steadily:
- Childhood prevalence rose from 3% to 7.2%, and the male-to-female ratio fell from 10:1 to 2:1.
- DSM-5 (2013) raised the age-of-onset cultoff from 7 to 12. It also recognized adult ADHD, requiring a lower symptom counts for adults.
- Impairment expanded as well. It now includes social and emotional domains, with a lower threshold.
- The list of other causes to consider (differential diagnoses) grew from 5 or 6 to 17, while “age-appropriate overactivity” fell off the list.
Outside of the DSM-based validation studies, the rates of diagnosed ADHD run even higher: about 20% of young adolescent boys in US CDC data, and over 20% of 5- to 20-year-olds in an Israeli health system. Ophir argues that when criteria applied in good faith yield rates two to three times what the manual expects, the fault lies more with the criteria than with clinicians.
He also points to internal contradictions. DSM-5-TR calls ADHD neurodevelopmental, yet concedes that no biomarker or neuroimaging finding can diagnose it and that symptoms may disappear in some settings, like the doctor’s office. Folding quiet, inattentive girls and disruptive, hyperactive boys into one category widens the construct further. More than 80% of clinic-referred cases carry at least one comorbid disorder, raising questions about what is causing the inattention.
Another Take
Four psychiatrists from the the University of Sydney responded to Ophir’s piece, lead by Gin Mahli. They concur that the criteria are poorly built:
- Symptoms are redundant, vague, and overlap with other conditions and with ordinary behavior.
- Thresholds, including age of onset, are arbitrary.
- DSM-5-TR defines “neurodevelopmental disorder” inconsistently.
- Prevalence rates and gender ratios vary widely across DSM editions and countries.
Clinicians fall back on personal judgment, which varies widely, and patients bear the cost of misdiagnosis.
The problem extends into research settings. In a scoping review of adult ADHD randomized controlled trials, a clinician made the diagnosis in only about a third of studies, and most trials did not assess for other psychiatric disorders.
Practice Implications
- Before diagnosing ADHD, complete a full psychiatric interview, rule out mood, anxiety, sleep (and sleep apnea), and substance use disorders.
- Try to confirm childhood onset with a parent interview or old school records.
- ADHD does not have a distinct cognitive fingerprint, so psychological and computerized testing does not clarify if the symptoms are due to ADHD or other problems.
—Chris Aiken, MD
Director, Psych Partners
Editor in Chief, Carlat Psychiatry Report







